Sarah Romano, Chief Financial Officer at First Wave BioPharma, Inc. (FWBI), sold 1,676 shares at $0.29 ($486) on 2023-10-04, disclosed to the SEC on 2023-10-06.
Open-market sale of $486 FWBI by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ENTO | SELL | 2024-07-03 | $664 | — | Filing → |
| FWBI | SELL | 2024-04-03 | $317 | — | Filing → |
| FWBI | SELL | 2024-03-19 | $6K | — | Filing → |